In the global pharmaceutical market, the demand for effective erectile dysfunction (ED) medications is rising rapidly. Among the latest-generation PDE5 inhibitors, Avanafil has emerged as a highly preferred option due to its fast action, strong safety profile, and superior patient tolerance. As worldwide demand grows, pharmaceutical exporters are increasingly turning toward Third party manufacturing of...











